As tumor cells often exhibit increased metabolic antioxidant capacity through Warburg effect to promote proliferation [48], we speculated that activation of mTOR facilitates sorafenib resistance through increasing cellular antioxidant capacity of liver cancer cells. The gene discussed is MTOR; the disease is liver cancer.